Request for post-marketing commitment progress update
Correspondence from Taiwan Food and Drug Administration regarding TFDA-2024-0031. Type: question. Risk: low. Category: Quality.
Correspondence ID
COR-031
Type
question
Application
Authority
Taiwan Food and Drug Administration
Category
Quality
Risk
Low
Due Date
2024-12-27
Status
Completed
Owner
Priya Sharma
Created
2022-11-20
Correspondence Body
Dear TFDA Review Team,
With reference to application TFDA-2024-0031, we wish to address the following:
[Detailed response body regarding request for post-marketing commitment progress update]
We trust this information is satisfactory. Please do not hesitate to contact us for further clarification.
Kind regards,
KCL BioPharm Regulatory Affairs
Response Package
Response package assembled: RP-031